Treatment of attention deficit hyperactivity disorder insomnia with blue wavelength light-blocking glasses

References

• Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163:716–723.
   PubMed Web of Science ®Google Scholar
• Philipsen A, Hornyak M, Riemann D. Sleep and sleep disorders in adults with attention deficit/hyperactivity disorder. Sleep Med Rev. 2006;10: 399–405.
   PubMed Web of Science ®Google Scholar
• Van Veen MM, Kooij JJ, Boonstra AM, Gordijn MC, Van Someren EJ. Delayed circadian rhythm in adults with attention-deficit/hyperactivity disorder and chronic sleep-onset insomnia. Biol Psychiatry. 2010;67:1091–1096.
   PubMed Web of Science ®Google Scholar
• Fargason RE, Gamble KL, Avis K, Cates M, May R, Besing R. Ramelteon for insomnia related to attention-deficit hyperactivity disorder. Psychopharmacol Bull. 2011;44:1–22.
   Google Scholar
• Fargason RE, White S, Hollar A, Gamble K. Adults with attention- deficit hyperactivity disorder without insomnia have subclinical sleep disturbance but not circadian delay: an ADHD phenotype? J Atten Disord. September 20, 2012. [Epub ahead of print.]
   Google Scholar
• Kissling C, Retz W, Wiemann S, et al. A polymorphism at the 3'-untranslated region of the CLOCK gene is associated with adult attention-deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 2008;147:333–338.
   PubMed Web of Science ®Google Scholar
• Xu X, Breen G, Chen CK, Huang YS, Wu YY, Asherson P. Association study between a polymorphism at the 3'-untranslated region of CLOCK gene and attention deficit hyperactivity disorder. Behav Brain Funct. 2010;6:48.
   PubMed Web of Science ®Google Scholar
• Schmidt TM, Chen SK, Hattar S. Intrinsically photosensitive retinal ganglion cells: many subtypes, diverse functions. Trends Neurosci. 2011;34:572–580.
   PubMed Web of Science ®Google Scholar
• Van der Heijden KB, Smits MG, Van Someren EJ, Gunning WB. Idiopathic chronic sleep onset insomnia in attention-deficit/ hyperactivity disorder: a circadian rhythm sleep disorder. Chronobiol Int. 2005;22:559–570.
   PubMed Web of Science ®Google Scholar
• Ingeborg M, van Geijlswijk IM, Korzilius HP, Smits MG. The use of exogenous melatonin in delayed sleep phase disorder: a meta-analysis. Sleep. 2010;33:1605–1614.
   Web of Science ®Google Scholar
• Burgess HJ, Revell VL, Molina TA, Eastman CI. Human phase response curves to three days of daily melatonin: 0.5 mg versus 3.0 mg. J Clin Endocrinol Metab. 2010;95:3325–3331.
   PubMed Web of Science ®Google Scholar
• Burgess HJ, Revell VL, Eastman CI. A three pulse phase response curve to three milligrams of melatonin in humans. J Physiol. 2008;586:639–647.
   PubMed Web of Science ®Google Scholar
• Rybak YE, McNeely HE, Mackenzie BE, Jain UR, Levitan RD. An open trial of light therapy in adult attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2006;67:1527–1535.
   PubMed Web of Science ®Google Scholar
• Terman M. Evolving applications of light therapy. Sleep Med Rev. 2007;11:497–507.
   PubMed Web of Science ®Google Scholar
• Benedetti F, Dallaspezia S, Fulgosi MC, Barbini B, Colombo C, Smeraldi E. Phase advance is an actimetric correlate of antidepressant response to sleep deprivation and light therapy in bipolar depression. Chronobiol Int. 2007;24:921–937.
   PubMed Web of Science ®Google Scholar
• Gooley JJ, Chamberlain K, Smith KA, et al. Exposure to room light before bedtime suppresses melatonin onset and shortens melatonin duration in humans. J Clin Endocrinol Metab. 2011;96:E463–E472.
   PubMed Web of Science ®Google Scholar
• Gooley JJ, Rajaratnam SM, Brainard GC, Kronauer RE, Czeisler CA, Lockley SW. Spectral responses of the human circadian system depend on the irradiance and duration of exposure to light. Sci Transl Med. 2010;2:31–33.
   Web of Science ®Google Scholar
• Johnson JE. Insomnia, alcohol, and over-the-counter drug use in older urban women. J Community Health Nurs. 1997;14:181–188.
   PubMedGoogle Scholar
• Rosenberg RP Sleep maintenance insomnia: strengths and weaknesses of current pharmacologic therapies. Ann Clin Psychiatry. 2006;18:49–56.
   Google Scholar
• Kayumov L, Casper RF, Hawa RJ, et al. Blocking low-wavelength light prevents nocturnal melatonin suppression with no adverse effect on performance during simulated shift work. J Clin Endocrinol Metab. 2005;90:2755–2761.
   PubMed Web of Science ®Google Scholar
• Sasseville A, Paquet N, Sevigny J, Hebert M. Blue blocker glasses impede the capacity of bright light to suppress melatonin production. J Pineal Res. 2006;41:73–78.
   PubMed Web of Science ®Google Scholar
• Burkhart K, Phelps JR. Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiol Int. 2009;26:1602–1612.
   PubMed Web of Science ®Google Scholar
• Sasseville A, Benhaberou-Brun D, Fontaine C, Charon MC, Hebert M. Wearing blue-blockers in the morning could improve sleep of workers on a permanent night schedule: a pilot study. Chronobiol Int. 2009;26:913–925.
   PubMed Web of Science ®Google Scholar
• Wirz-Justice A, Bromundt V, Cajochen C. Circadian disruption and psychiatric disorders: the importance of entrainment. Sleep Med Clin. 2009;4:273–284.
   Google Scholar
• Phelps J. Dark therapy for bipolar disorder using amber lenses for blue light blockade. Med Hypotheses. 2008;70:224–229.
   PubMed Web of Science ®Google Scholar
• Sletten TL, Revell VL, Middleton B, Lederle KA, Skene DJ. Age-related changes in acute and phase-advancing resonses to monochromatic light. J Biol Rhythms. 2009;24:73–89.
   PubMed Web of Science ®Google Scholar
• Friedman L, Zeitzer JM, Kushida C, et al. Scheduled bright light for treatment of insomia in older adults. J Am Geriatr Soc. 2009;57:441–452.
   PubMed Web of Science ®Google Scholar
• Harada T. Effects of evening light conditions on salivary melatonin of Japanese junior high school students. J Circadian Rhythms. 2004;2:4.
   PubMedGoogle Scholar
• Buysse DJ, Reynolds CF, III, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213.
   PubMed Web of Science ®Google Scholar
• Backhaus J, Junghanns K, Broocks A, Riemann D, Hohagen F. Test- retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia. J Psychosom Res. 2002;53:737–740.
   PubMed Web of Science ®Google Scholar
• Buysse DJ, Hall ML, Strollo PJ, et al. Relationships between the Pittsburgh sleep quality index (PSQI), Epworth sleepiness scale (ESS), and clinical/polysomnographic measures in a community sample. J Clin Sleep Med. 2008;4:563–571.
   PubMed Web of Science ®Google Scholar
• Zavada A, Gordijn MC, Beersma DG, Daan S, Roenneberg T. Comparison of the Munich chronotype questionnaire with the Horne-Ostberg’s morningness-eveningness score. Chronobiol Int. 2005;22:267–278.
   PubMed Web of Science ®Google Scholar
• Scharf MB, Roth T, Vogel GW, Walsh JK. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia. J Clin Psychiatry. 1994;55:192–199.
   PubMed Web of Science ®Google Scholar
• Zammit GK, McNabb LJ, Caron J, Amato DA, Roth T. Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia. Curr Med Res Opin. 2004;20:1979–1991.
   PubMed Web of Science ®Google Scholar
• Munch M, Kobialka S, Steiner R, Oelhafen P, Wirz-Justice A, Cajochen C. Wavelength-dependent effects of evening light exposure on sleep architecture and sleep EEG power density in men. Am J Physiol Regul Integr Comp Physiol. 2006;290:R1421–R1428.
   PubMed Web of Science ®Google Scholar
• Novakova M, Paclt I, Ptacek R, Kuzelova H, Hajek I, Sumova A. Salivary melatonin rhythm as a marker of the circadian system in healthy children and those with attention-deficit/hyperactivity disorder. Chronobiol Int. 2011;28:630–637.
   PubMed Web of Science ®Google Scholar